Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...

In a notification issued on Sunday, the NBR said it had slashed the tax at source on the import of ingredients for oncology ...

Under the deal, Sun Pharma will buy the outstanding shares of the Massachusetts-based company for $4.10 each, representing a premium of approximately 66% to Checkpoint’s closing share price last ...

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...